Diversity Management, News and Updates
Originally published at jnj.com. Johnson & Johnson is a DiversityInc Hall of Fame company. The U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) convened on April 14 to consider reports of an extremely rare disorder involving blood clots in combination with low platelets…
Fauci blames “double whammy” and institutional racism for increased COVID-19 impact on the Black community. As the COVID-19 crisis rages on, Black and Brown Americans are still being impacted at a disproportionate rate, with death and infections rates more than 30% higher than those of whites. And following similar comments…
A coalition of leading CEOs and organizations are coming together today to announce the formation of OneTen, an organization that will combine the power of these committed American companies to upskill, hire and promote one million Black Americans over the next 10 years into family-sustaining jobs with opportunities for advancement. In…
The Re-Ignite program at Johnson & Johnson (DiversityInc Hall of Fame) is aimed at helping STEM professionals relaunch their careers after breaks from the field. It began as a pilot in 2017 and transitioned into a company-wide talent development initiative. Liz Markus, director of the program, spoke with DiversityInc about…
Johnson & Johnson (A DiversityInc Hall of Fame Company) announced it has a lead candidate for a potential vaccine for COVID-19, the pandemic sweeping the world and killing thousands. “The world is facing an urgent public health crisis and we are committed to doing our part to make a COVID-19 vaccine available…
Originally published on jnj.com. From robotics solutions for orthopedic surgery to the potential to bring new hope to patients living with multiple myeloma through CAR-T, these are just some of the cutting-edge projects that these visionaries think could potentially help propel healthcare forward around the globe. As 2019 came to…
Originally published on jnj.com. Up to 200,000 Regimens of Janssen’s Investigational Ebola Vaccine to be Supplied to Rwanda for Use in Border Region near Democratic Republic of the Congo (DRC) Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will provide up to 200,000 Ebola vaccine regimens to the…
Ensuring diversity and inclusivity in the workplace doesn’t just happen, individuals and organizations must take action to do things differently. Johnson& Johnson, The Hershey Company and EY created a coalition aimed at creating opportunities to advance people of color in supply chain jobs that plan, source, make and deliver products….
Originally Published by Johnson & Johnson Analysis shows consistent renal and cardiovascular benefit when treated with INVOKANA® even when patients had moderate to severe renal deficiency INVOKANA® is the only diabetes medicine indicated to slow the progression of diabetic nephropathy (also known as DKD) and reduce the risk of hospitalization for heart…
Originally Published by Johnson & Johnson Johnson & Johnson (NYSE: JNJ), the world’s largest and most broadly-based healthcare company, today published You Belong: Diversity & Inclusion Impact Review (Impact Review), which demonstrates how a strategic Diversity & Inclusion (D&I) philosophy has been a key driver of innovation and impactful business outcomes since…